Characteristics of Appendicitis After Immune Checkpoint Inhibitors Among Cancer Patients

被引：0
|
作者：
Mathew, Antony [1 ]
Shatila, Malek [2 ]
Lai, Zongshan [2 ]
Tan, Dongfeng [2 ]
Oliva, Isabella Glitza [2 ]
Wang, Jianbo [2 ]
Alhalabi, Omar [2 ]
Zhang, Hao Chi [2 ]
Thomas, Anusha S. [2 ]
Wang, Yinghong [2 ]
机构：
[1] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2022年 / 117卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S183
引用
收藏
页码：S133 / S134
页数：2
相关论文
共 50 条
  • [31] Risk of Knowledge Gaps Among Nononcologists Caring for Patients With Cancer: The Example of Immune Checkpoint Inhibitors
    Bourne, Garrett
    Das, Devika
    Jacobson, Joseph O.
    Sadeghi, Navid
    JCO ONCOLOGY PRACTICE, 2024, 20 (10)
  • [32] Outcomes after retreatment with MAPK inhibitors and immune checkpoint inhibitors in melanoma patients
    Persa, Oana D.
    Mauch, Cornelia
    FUTURE ONCOLOGY, 2021, 17 (29) : 3809 - 3817
  • [33] Characteristics and Prognosis of Acquired Resistance to Immune Checkpoint Inhibitors in Gastrointestinal Cancer
    Zhuo, Na
    Liu, Chang
    Zhang, Qi
    Li, Jian
    Zhang, Xiaotian
    Gong, Jifang
    Lu, Ming
    Peng, Zhi
    Zhou, Jun
    Wang, Xicheng
    Jiao, Xi
    Wang, Yujiao
    Wang, Yanni
    Gao, Mengting
    Shen, Lin
    Lu, Zhihao
    JAMA NETWORK OPEN, 2022, 5 (03)
  • [34] Efficacy and predictors of immune checkpoint inhibitors in patients with gallbladder cancer
    Cheng, Zhuo
    Yang, Cheng
    Zhao, Qian
    Zhong, Jingjiao
    Zhang, Jin
    Jin, Riming
    Li, Yao
    Ta, Na
    Wu, Dong
    Yuan, Zhengang
    Sun, Wen
    Wang, Ruoyu
    CANCER SCIENCE, 2024, 115 (06) : 1979 - 1988
  • [35] Immune checkpoint inhibitors in cancer patients with COVID-19
    Pan, Yun
    Tan, Jiaxiong
    Li, Jinzhong
    Li, Taoyuan
    Li, Jieying
    Cao, Yang
    Yang, Liu
    Lin, Xunge
    Li, Minran
    Liang, Xujing
    OPEN LIFE SCIENCES, 2023, 18 (01):
  • [36] Nephrotoxicity in patients with cancer treated with immune checkpoint inhibitors.
    Papaiakovou, Evangelos Eleutherakis
    Kastritis, Efstathios
    Zagouri, Flora
    Grapsa, Dimitra
    Ntanassis-Stathopoulos, Ioannis
    Stefanou, Dimitra
    Evangelou, Georgios
    Kotteas, Ilias
    Dimopoulos, Meletios A.
    Syrigos, Konstantinos
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [37] Efficacy and predictors of immune checkpoint inhibitors in patients with gallbladder cancer
    Cheng, Zhuo
    Yang, Cheng
    Zhao, Qian
    Zhong, Jingjiao
    Zhang, Jin
    Jin, Riming
    Li, Yao
    Ta, Na
    Wu, Dong
    Yuan, Zhengang
    Sun, Wen
    Wang, Ruoyu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] Investigating Pneumonitis in Cancer Patients Receiving Immune Checkpoint Inhibitors
    Moodabagil, M.
    Easterling, R.
    Peng, J.
    Ma, J.
    Zimmer, J.
    Viveiros, M.
    Meara, A.
    Donnelly, E.
    Owen, D.
    Ho, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [39] Development of tuberculosis in cancer patients receiving immune checkpoint inhibitors
    Im, Yunjoo
    Lee, Jeeyun
    Kim, Seok Jin
    Koh, Won-Jung
    Jhun, Byung Woo
    Lee, Se-Hoon
    RESPIRATORY MEDICINE, 2020, 161
  • [40] Rheumatic complications in cancer patients treated with immune checkpoint inhibitors
    Lee, Kyung-Ann
    Kim, Hae-Rim
    Yoon, So Young
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (06): : 1197 - 1209
12345